Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes

被引:322
作者
Moretta, A
Biassoni, R
Bottino, C
Pende, D
Vitale, M
Poggi, A
Mingari, MC
Moretta, L
机构
[1] UNIV BRESCIA, DIPARTIMENTO SCI BIOMED & BIOTECNOL, I-25121 BRESCIA, ITALY
[2] INST SCI TUMORI, GENOA, ITALY
[3] CTR BIOTECNOL AVANZATE, GENOA, ITALY
[4] UNIV GENOA, IST PATOL GEN, I-16126 GENOA, ITALY
[5] UNIV GENOA, IST ONCOL CLIN & SPERIMENTALE, I-16126 GENOA, ITALY
[6] UNIV GENOA, IST ISTOL & EMBRIOL GEN, I-16126 GENOA, ITALY
关键词
D O I
10.1111/j.1600-065X.1997.tb00943.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human NK cells express several specialized inhibitory receptors that recognize major histocompatibility complex (MHC) class I molecules expressed on normal cells. The lack of expression of one or more HLA class I alleles leads to NK-mediated target cell lysis. Receptors specific for groups of HLA-C (p58), HLA-B (p70) and HLA-A (p140) alleles belong to the Ig superfamily with two or three Ig-like domains in their extracellular portion, and a long cytoplasmic tail containing ITIM motifs and associated with a non-polar transmembrane portion. In contrast, the CD94/NKG2-A receptor complex is composed of type II proteins with a C-type lectin domain which displays a more broad specificity for different class I alleles. Recently, activatory forms of the HLA-C-specific receptors have been identified in some donors. They are virtually identical to the inhibitory forms in their extracellular portions, but display a short cytoplasmic tail lacking ITIM motifs associated with a Lys-containing transmembrane portion (p50). A subset of activated T-lymphocytes, primarily CD8+ and oligoclonal or monoclonal in nature, express NK-type class I-specific receptors. These receptors exert an inhibitory activity on T-cell receptor-mediated functions and may provide an important mechanism of downregulation of T-cell responses.
引用
收藏
页码:105 / 117
页数:13
相关论文
共 92 条
[81]   CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: Identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies [J].
Sivori, S ;
Vitale, M ;
Bottino, C ;
Marcenaro, E ;
Sanseverino, L ;
Parolini, S ;
Moretta, L ;
Moretta, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (10) :2487-2492
[82]  
STORKUS WJ, 1987, J IMMUNOL, V138, P1657
[83]   OF ITAMS AND ITIMS - TURNING ON AND OFF THE B-CELL ANTIGEN RECEPTOR [J].
THOMAS, ML .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (06) :1953-1956
[84]   BIOLOGY OF NATURAL-KILLER CELLS [J].
TRINCHIERI, G .
ADVANCES IN IMMUNOLOGY, 1989, 47 :187-376
[85]   Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) tax-specific CD8(+) cytotoxic T lymphocytes from patients with HTLV-1-associated disease: Evidence for oligoclonal expansion [J].
Utz, U ;
Banks, D ;
Jacobson, S ;
Biddison, WE .
JOURNAL OF VIROLOGY, 1996, 70 (02) :843-851
[86]   COEXPRESSION OF 2 FUNCTIONALLY INDEPENDENT P58 INHIBITORY RECEPTORS IN HUMAN NATURAL-KILLER-CELL CLONES RESULTS IN THE INABILITY TO KILL ALL NORMAL ALLOGENEIC TARGET-CELLS [J].
VITALE, M ;
SIVORI, S ;
PENDE, D ;
MORETTA, L ;
MORETTA, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (08) :3536-3540
[87]   Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: Their role in the definition of different groups of alloreactive NK cell clones [J].
Vitale, M ;
Sivori, S ;
Pende, D ;
Augugliaro, R ;
DiDonato, C ;
Amoroso, A ;
Malnati, M ;
Bottino, C ;
Moretta, L ;
Moretta, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (04) :1453-1457
[88]   MOLECULAR CLONES OF THE P58 NK CELL-RECEPTOR REVEAL IMMUNOGLOBULIN-RELATED MOLECULES WITH DIVERSITY IN BOTH THE EXTRACELLULAR AND INTRACELLULAR DOMAINS [J].
WAGTMANN, N ;
BIASSONI, R ;
CANTONI, C ;
VERDIANI, S ;
MALNATI, MS ;
VITALE, M ;
BOTTINO, C ;
MORETTA, L ;
MORETTA, A ;
LONG, EO .
IMMUNITY, 1995, 2 (05) :439-449
[89]   Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer [J].
Wagtmann, N ;
Rajagopalan, S ;
Winter, CC ;
Peruzzi, M ;
Long, EO .
IMMUNITY, 1995, 3 (06) :801-809
[90]  
WANG ECY, 1995, J IMMUNOL, V155, P5046